SCHEMBL31073259

SCHEMBL31073259

CC(C)(c1ccc(CO[Si](C)(C)C(C)(C)C)cc1)N1CCN(c2ccc([N+](=O)[O-])nc2)CC1

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.49
POLB P06746 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.45
RAB9A P51151 1/20 0.43
CHRNB2 P17787 2/20 0.37
CHRNB4 P30926 2/20 0.37
CHRNA3 P32297 2/20 0.37
CHRNA4 P43681 2/20 0.37
TGM2 P21980 3/20 0.36
GPR119 Q8TDV5 2/20 0.35
HSD11B1 P28845 1/20 0.34
MET P08581 2/20 0.34
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
HTT P42858 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31073430 0.83 POLB (0.48) MAPTPOLBSMN1; SMN2RAB9ACHRNB2
SCHEMBL31073373 0.83 POLB (0.48) MAPTPOLBSMN1; SMN2RAB9ACHRNB2
SCHEMBL31073002 0.83 GCK (0.38) GPR119
SCHEMBL31073083 0.83 POLB (0.47) MAPTPOLBSMN1; SMN2RAB9ACHRNB2
SCHEMBL31073487 0.83 POLB (0.47) MAPTPOLBSMN1; SMN2RAB9ACHRNB2
SCHEMBL31073252 0.81 MAPT (0.50) MAPTPOLBSMN1; SMN2RAB9ACHRNB2
SCHEMBL31072975 0.81 MAPT (0.50) MAPTPOLBSMN1; SMN2RAB9ACHRNB2
SCHEMBL31073444 0.78 MAPT (0.44) MAPTPOLBSMN1; SMN2RAB9ACHRNB2
SCHEMBL4696975 0.75 MAPT (0.67) MAPTPOLBSMN1; SMN2RAB9ACHRNB2
SCHEMBL31607956 0.74 POLB (0.51) MAPTPOLBSMN1; SMN2RAB9ACHRNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024173646-A1 CYCLIN-DEPENDENT KINASE DEGRADING COMPOUNDS INNOVO THERAPEUTICS, INC. (US) 2024-08-22 WO disclosed